Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Market Online’s Weekly Cannabis Report – March 1, 2024

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| March 1, 2024

{{labelSign}}  Favorites
{{errorMessage}}

Tilray Brands Inc. (TSX:TLRY) provided an update on Germany’s milestone cannabis legalization and what it means for the future of cannabis in Europe and for the company. The German Medical Cannabis Act provides for the abolishment of the tender process for in-country cultivation of medicinal cannabis and replaces it with a licensing scheme.

Click to enlarge
Tilray Brands | Source: Brewbound

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Top Story: Aurora (TSX:ACB) partners with Script assist to provide better access to U.K. medical cannabis

2 | Xebra Brands (CSE:XBRA) receives its first approval for legal CBD in Mexico

3 | Nevis Brands (CSE:NEVI) begins sales of its Major beverage in California

Click to enlarge

Top Cannabis Stocks Feb. 23 to Feb. 29, 2024

1. T.TLRY | 18,473 views | Tilray Brands Inc.
2. T.WEED | 9,684 views | Canopy Growth Corp.
3.T.LABS | 5,623 views | Medipharm Labs Corp.
4. C.OILS | 3,679 views | Nextleaf Solutions Inc.
5. T.CURA | 2,345 views | Curaleaf Holdings Inc.
6.T.CBA| 1,624 views | Aurora Cannabis Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.




{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today